%0 Journal Article
%T Diversifying clinical trials
%J -
%D 2018
%R https://doi.org/10.1038/s41591-018-0303-4
%X Scientific common sense and social justice dictate that the safety and efficacy of new therapies must be tested in the patient populations in need of treatment. Yet a recent study found that African Americans have been dramatically underrepresented in US clinical trials for cancer drugs. Efforts to increase the participation of minorities in clinical trials must become a priority for all drug developers
%U https://www.nature.com/articles/s41591-018-0303-4